Use of beta blockers is associated with hearing loss

References

• Agrawal, Y., E. A. Platz, and J. K. Niparko. 2008. “Prevalence of Hearing Loss and Differences by Demographic Characteristics among US Adults: Data from the National Health and Nutrition Examination Survey, 1999-2004.” Archives of Internal Medicine 168: 1522–1530.
   PubMed Web of Science ®Google Scholar
• Ahles, A., and S. Engelhardt. 2014. “Polymorphic Variants of Adrenoceptors: Pharmacology, Physiology, and Role in Disease.” Pharmacological Reviews 66: 598–637.
   PubMed Web of Science ®Google Scholar
• Bangalore, S., D. Wild, S. Parkar, M. Kukin, and F. H. Messerli. 2008. “Beta-Blockers for Primary Prevention of Heart Failure in Patients with Hypertension Insights from a Meta-Analysis.” Journal of the American College of Cardiology 52: 1062–1072.
   PubMed Web of Science ®Google Scholar
• Cai, J., J. Li, Y. Mao, X. Bai, L. Xu, and H. Wang. 2013. “Immunohistochemical Localization of α2-Adrenergic Receptors in the Neonatal Rat Cochlea and the Vestibular Labyrinth.” Journal of Molecular Neuroscience 51: 1010–1020.
   PubMed Web of Science ®Google Scholar
• Chang, J., N. Ryou, H. J. Jun, S. Y. Hwang, J.-J. Song, S. W. Chae, and H. de Wit. 2016. “Effect of Cigarette Smoking and Passive Smoking on Hearing Impairment: Data from a Population-Based Study.” PLoS One 11: e0146608. doi:10.1371/journal.pone.0146608.
   PubMed Web of Science ®Google Scholar
• Chatterjee, S., G. Biondi-Zoccai, A. Abbate, F. D'Ascenzo, D. Castagno, B. Van Tassell, D. Mukherjee, and E. Lichstein. 2013. “Benefits of β Blockers in Patients with Heart Failure and Reduced Ejection Fraction: Network Meta-Analysis.” BMJ (Clinical Research Ed.) 346: f55. doi: 10.1136/bmj.f55.
   PubMedGoogle Scholar
• Chen, Z. M., H. C. Pan, Y. P. Chen, R. Peto, R. Collins, L. X. Jiang, J. X. Xie, and L. S. Liu. 2005. “Early Intravenous Then Oral Metoprolol in 45,852 Patients with Acute Myocardial Infarction: Randomised Placebo-Controlled Trial.” Lancet (London, England) 366: 1622–1632.
   PubMed Web of Science ®Google Scholar
• Chobanian, A. V., G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, and D. W. Jones. 2003. “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report.” JAMA 289: 2560–2572.
   PubMed Web of Science ®Google Scholar
• Facchini, E., A. Degiovanni, C. Cavallino, A. Lupi, A. Rognoni, and A. S. Bongo. 2015. “Beta-Blockers and Nitrates: Pharmacotherapy and Indications.” Cardiovascular & Hematological Agents in Medicinal Chemistry 13: 25–30.
   PubMedGoogle Scholar
• Fäldt, R., H. Liedholm, and J. Aursnes. 1984. “Beta Blockers and Loss of Hearing. British Medical Journal (Clinical Research Ed.). 289: 1490–1492.
   PubMedGoogle Scholar
• Fauser, C., S. Schimanski, and P. Wangemann. 2004. “Localization of Beta1-Adrenergic Receptors in the Cochlea and the Vestibular Labyrinth.” The Journal of Membrane Biology 201: 25–32.
   PubMed Web of Science ®Google Scholar
• Fisker, F. Y., D. Grimm, and M. Wehland. 2015. “Third-Generation Beta-Adrenoceptor Antagonists in the Treatment of Hypertension and Heart Failure.” Basic: Clinical Pharmacology, Toxicology 117: 5–14.
   PubMed Web of Science ®Google Scholar
• Geffner, D. L., and J. M. Hershman. 1992. “Beta-Adrenergic Blockade for the Treatment of Hyperthyroidism.” The American Journal of Medicine 93: 61–68.
   PubMed Web of Science ®Google Scholar
• Hilas, O., and D. Ezzo. 2009. “Nebivolol (Bystolic), a NOVEL BETA BLOCKER for Hypertension. P & T: A Peer-Reviewed Journal for Formulary Management. 34: 188–192.
   PubMedGoogle Scholar
• British Society of Audiology 2011. Pure-Tone Air-Conduction and Bone-Conduction Threshold Audiometry With and Without Masking. Recommended Procedure Pure Tone Audiometry. Accessed 11 September 2016. http://www.thebsa.org.uk/wp-content/uploads/2014/04/BSA_RP_PTA_FINAL_24Sept11_MinorAmend06Feb12.pdf
   Google Scholar
• World Health Organization (WHO). 2016. Grades of Hearing Impairment. Accessed 28 December 2016. http://www.who.int/pbd/deafness/hearing_impairment_grades/en/
   Google Scholar
• Jones, R. F., V. T. Hammond, D. Wright, and J. C. Ballantyne. 1977. “Practolol and Deafness.” The Journal of Laryngology and Otology 91: 963–972.
   PubMed Web of Science ®Google Scholar
• Jonsson, G., M. Abdelnoor, C. Müller, S. E. Kjeldsen, I. Os, and A. Westheim. 2005. “A Comparison of the Two Beta-Blockers Carvedilol and Atenolol on Left Ventricular Ejection Fraction and Clinical Endpoints after Myocardial Infarction. A Single-Centre, Randomized Study of 232 Patients.” Cardiology 103: 148–155.
   PubMed Web of Science ®Google Scholar
• Khan, K. M., M. J. Drescher, J. S. Hatfield, N. A. Ramakrishnan, and D. G. Drescher. 2007. “Immunohistochemical Localization of Adrenergic Receptors in the Rat Organ of Corti and Spiral Ganglion.” Journal of Neuroscience Research 85: 3000–3012.
   PubMed Web of Science ®Google Scholar
• Koo, J. W., L. Quintanilla-Dieck, M. Jiang, J. Liu, Z. D. Urdang, J. J. Allensworth, C. P. Cross, H. Li, and P. S. Steyger. 2015. “Endotoxemia-Mediated Inflammation Potentiates Aminoglycoside-Induced Ototoxicity.” Science Translational Medicine 7: 298ra118.
   PubMed Web of Science ®Google Scholar
• Lanvers-Kaminsky, C., A. A. Zehnhoff-Dinnesen, R. Parfitt, and G. Ciarimboli. 2017. “Drug-Induced Ototoxicity: Mechanisms, Pharmacogenetics, and Protective Strategies.” Clinical Pharmacology & Therapeutics 101: 491–500.
   PubMed Web of Science ®Google Scholar
• Leis, J. A., J. A. Rutka, and W. L. Gold. 2015. “Aminoglycoside-Induced Ototoxicity.” Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne 187: E52. doi: 10.1503/cmaj.140339.
   PubMed Web of Science ®Google Scholar
• Lindholm, L. H., B. Carlberg, and O. Samuelsson. 2005. “Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.” Lancet (London, England) 366: 1545–1553.
   PubMed Web of Science ®Google Scholar
• Mason, J. W. 1993. “A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.” The New England Journal of Medicine 329: 452–458.
   PubMed Web of Science ®Google Scholar
• Metra, M.,. R. Giubbini, S. Nodari, E. Boldi, M. G. Modena, and L. Dei Cas. 2000. “Differential Effects of Beta-Blockers in Patients with Heart Failure: A Prospective, Randomized, Double-Blind Comparison of the Long-Term Effects of Metoprolol versus Carvedilol.” Circulation 102: 546–551.
   PubMed Web of Science ®Google Scholar
• Packer, M., M. B. Fowler, E. B. Roecker, A. J. S. Coats, H. A. Katus, H. Krum, and P. Mohacsi. 2002. “Effect of Carvedilol on the Morbidity of Patients with Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study.” Circulation 106: 2194–2199.
   PubMed Web of Science ®Google Scholar
• Priori, S. G., C. Blomström-Lundqvist, A. Mazzanti, N. Blom, M. Borggrefe, J. Camm, P. M. Elliott, D. Fitzsimons, R. Hatala. 2016. “[2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. The Task Force for the Management of Patients ;with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].” Giornale Italiano Di Cardiologia 17: 108–170.
   Web of Science ®Google Scholar
• Ripley, T. L., and J. J. Saseen. 2014. “β-Blockers: A Review of Their Pharmacological and Physiological Diversity in Hypertension.” The Annals of Pharmacotherapy 48: 723–733.
   PubMed Web of Science ®Google Scholar
• Schimanski, S., M. A. Scofield, and P. Wangemann. 2001. “Functional Beta-2 Adrenergic Receptors Are Present in Non Strial Tissues of the Lateral Wall in the Gerbil Cochlea. Audiology and Neurotology 6: 124–131.
   PubMed Web of Science ®Google Scholar
• Silvet, H., F. Spencer, J. Yarzebski, D. Lessard, J. M. Gore, and R. J. Goldberg. 2003. “Community Wide Trends in the Use and Outcomes Associated with Beta-Blockers in Patients with Acute Myocardial Infarction: The Worcester Heart Attack Study.” Archives of Internal Medicine 163: 2175–2183.
   PubMedGoogle Scholar
• Tagami, T. Y. Yambe, and T. Tanaka. 2012. “Short-Term Effects of β-Adrenergic Antagonists and Methimazole in New-Onset Thyrotoxicosis Caused by Graves' Disease.” Internal Medicine 51: 2285–2290.
   PubMed Web of Science ®Google Scholar
• Wangemann, P., J. Liu, M. Shimozono, S. Schimanski, and M. A. Scofield. 2000. “K+ Secretion in Strial Marginal Cells Is Stimulated via Beta 1-Adrenergic Receptors but Not via Beta 2-Adrenergic or Vasopressin Receptors.” The Journal of Membrane Biology 175: 191–202.
   PubMed Web of Science ®Google Scholar
• Wangemann, P., J. Liu, M. Shimozono, and M. A. Scofield. 1999. “Beta1-Adrenergic Receptors but not Beta2-Adrenergic or Vasopressin Receptors Regulate K + secretion in Vestibular Dark Cells of the Inner Ear.” The Journal of Membrane Biology 170: 67–77.
   PubMed Web of Science ®Google Scholar
• Wojciechowski, D., and V. Papademetriou. 2008. “Beta-Blockers in the Management of Hypertension: Focus on Nebivolol.” Expert Review of Cardiovascular Therapy 6: 471–479.
   PubMedGoogle Scholar
• Yang, C. H., T. Schrepfer, and J. Schacht. 2015. “Age-Related Hearing Impairment and the Triad of Acquired Hearing Loss.” Frontiers in Cellular Neuroscience 9: 276. doi: 10.3389/fncel.2015.00276. eCollection 2015.
   PubMed Web of Science ®Google Scholar
• Zesiewicz, T. A., R. J. Elble, E. D. Louis, G. S. Gronseth, W. G. Ondo, R. B. Dewey, M. S. Okun, K. L. Sullivan and W. J. Weiner. 2011. “Evidence-Based Guideline Update: Treatment of Essential Tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology.” Neurology 77: 1752–1755.
   PubMed Web of Science ®Google Scholar